Work

60 Extended Cc-486 (oral Azacitidine) Dosing in Patients With Myelodysplastic Syndromes (mds), Acute Myeloid Leukemia (aml), or Chronic Myelomonocytic Leukemia (cmml): Safety, Tolerability, and Response

Year: 2015

Type: article

Source: Leukemia Research

DOI: 10.1016/s0145-2126(15)30061-8

Authors: M.R. Savona, K. Kolibaba, P. Conkling, E.C. Kingsley, C. Becerra, J.C. Morris, R.M. Rifkin, E. Laille, A. Kellerman, S.M. Ukrainskyj, Q. Dong, B.S. Skikne

Language: English

Topic: Acute Myeloid Leukemia Research

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2037975559

FWCI:

Cites:

Cited by:

Related to: 10